Meena Dalal – Trialguna
View Detailed Executive Profile →Professional Overview
- Meena Dalal is the Founder and CEO of TrialGuna, Comprehensive Clinical Research Solution, a role initiated in June 2019.
- Under Meena Dalal's leadership, TrialGuna has focused on providing comprehensive clinical research solutions, aiming to enhance the efficiency and effectiveness of clinical trials.
- Prior to founding TrialGuna, Meena Dalal served as Chief Executive Officer at the same organization starting in July 2019, indicating a seamless transition into a leadership role focused on strategic growth and development.
- Meena Dalal gained valuable experience as the Senior Centralized Monitoring Lead at IQVIA from December 2018 until June 2019, contributing significant expertise in clinical monitoring practices.
- While at IQVIA, Meena also held the position of Centralized Monitoring Lead from December 2015 to June 2019, further enhancing skills in centralized clinical research methodologies.
- Before joining IQVIA, Meena Dalal was the Dean of Ace Creative Learning Pvt. Ltd. from May 2013 until May 2015, showcasing an ability to influence educational initiatives and leadership development.
- Meena's clinical research background includes positions such as Senior Clinical Research Associate at Max Neeman International from June 2012 to May 2013 and at Semler Research Center from June 2010 to March 2012, demonstrating a strong foundation in clinical research practices.
- Meena Dalal began the career journey as a Clinical Trial Assistant at Max Neeman from June 2009 to March 2010, indicating an early commitment to the clinical research field.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Ace Creative Learning Pvt. Ltd. | Dean | May 2013 – Dec 2015 |
| Max Neeman International | Senior Clinical Research Associate | Jun 2012 – May 2013 |
| Semler Research Center | Senior Clinical Research Associate | Jun 2010 – May 2012 |
| Max Neeman | CTA | Jun 2009 – Mar 2010 |
| IQVIA | Sr. Centralised Monitoring lead | Dec 2018 – Jun 2019 |
| IQVIA | Centralized Monitoring lead | Dec 2015 – Jun 2019 |
| TrialGuna, Comprehensive Clinical Research Solution | Founder & CEO | Jun 2019 – Present |
| TrialGuna, Comprehensive Clinical Research Solution | Chief Executive Officer | Jul 2019 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Trialguna corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Meena Dalal's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Trialguna's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)